Tinkering and tailoring with HCV therapy: can we get away with less?

Review

Amany Zekry et al. Hepatology. 2004 Dec.

. 2004 Dec;40(6):1249-51.

doi: 10.1002/hep.20513.

No abstract available

Comment on

Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study.
Dalgard O, Bjøro K, Hellum KB, Myrvang B, Ritland S, Skaug K, Raknerud N, Bell H. Dalgard O, et al. Hepatology. 2004 Dec;40(6):1260-5. doi: 10.1002/hep.20467. Hepatology. 2004. PMID: 15558712 Clinical Trial.

[Hepatitis C and B (HCV, HBV)].
Violante MD. Violante MD. Rev Gastroenterol Mex. 2006 Aug;71 Suppl 1:101-3. Rev Gastroenterol Mex. 2006. PMID: 17037789 Review. Spanish. No abstract available.
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
Rockstroh JK, Bhagani S, Benhamou Y, Bruno R, Mauss S, Peters L, Puoti M, Soriano V, Tural C; EACS Executive Committee. Rockstroh JK, et al. HIV Med. 2008 Feb;9(2):82-8. doi: 10.1111/j.1468-1293.2007.00535.x. HIV Med. 2008. PMID: 18257771
Endpoints for clinical trials on treatment of hepatitis C.
Kang H, Lok AS. Kang H, et al. J Hepatol. 2006 Oct;45(4):473-5. doi: 10.1016/j.jhep.2006.07.007. Epub 2006 Jul 25. J Hepatol. 2006. PMID: 16901577 Review. No abstract available.
Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
de Bruijne J, Buster EH, Gelderblom HC, Brouwer JT, de Knegt RJ, van Erpecum KJ, Schalm SW, Bakker CM, Zaaijer HL, Janssen HL, Reesink HW; Netherlands Association of Gastroenterologists and Hepatologists. de Bruijne J, et al. Neth J Med. 2008 Jul-Aug;66(7):311-22. Neth J Med. 2008. PMID: 18663263 Review.
Future directions in therapy for chronic hepatitis C.
Jensen DM, Ascione A. Jensen DM, et al. Antivir Ther. 2008;13 Suppl 1:31-6. Antivir Ther. 2008. PMID: 18432161 Review.